Nazlı Ataç

413 citations
14 papers · 335 indexed · h-index 8
Topics
Antibiotic Resistance in Bacteria (5 papers)Nanoplatforms for cancer theranostics (4 papers)Photodynamic Therapy Research Studies (3 papers)

In The Last Decade

Nazlı Ataç

14 papers receiving 335 citations

Peers

Nazlı Ataç
Comparison fields: 5 of 77
  • Pulmonary and Respiratory Medicine 119
  • Biomedical Engineering 111
  • Molecular Medicine 79
  • Physiology 66
  • Materials Chemistry 50
Replace Alireza Jafari with:
Alireza Jafari Iran
Leela Kakithakara Vajravelu India
Mario Guerrieri Italy
Gordon MacGregor United Kingdom
Shuang Tian China
Vidya Pai India
Haidy G. Rivero United States
Behzad Khosrovi United Kingdom
Alhusain J. Alzahrani Saudi Arabia
Przemysław Wolak Poland
Nazlı Ataç relative to Alireza Jafari Iran Alireza Jafari's profile →
Citations per field
00.5×3.3×
Alireza Jafari · 1×
Citations per year

Countries citing papers authored by Nazlı Ataç

Since Specialization
Citations

This map shows the geographic impact of Nazlı Ataç's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nazlı Ataç with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nazlı Ataç more than expected).

Fields of papers citing papers by Nazlı Ataç

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nazlı Ataç. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nazlı Ataç. The network helps show where Nazlı Ataç may publish in the future.

Co-authorship network of co-authors of Nazlı Ataç

This figure shows the co-authorship network connecting the top 25 collaborators of Nazlı Ataç. A scholar is included among the top collaborators of Nazlı Ataç based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nazlı Ataç. Nazlı Ataç is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 2
2 4
3 17
4 4
5 1
6 5
7 1
8 23
9 88
10 28
11 47
12 10
13 59
14 46

About Nazlı Ataç

Nazlı Ataç is a scholar working on Molecular Medicine, Endocrinology and Applied Microbiology and Biotechnology, having authored 14 papers that have together received 335 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (5 papers), Nanoplatforms for cancer theranostics (4 papers) and Photodynamic Therapy Research Studies (3 papers). The work is most often cited by research in Molecular Medicine (79 citations), Endocrinology (35 citations) and Applied Microbiology and Biotechnology (13 citations). Nazlı Ataç has collaborated with scholars based in Türkiye, United States and Switzerland. Frequent co-authors include Füsun Can, Özlem Yalçın, Oğuz K. Başkurt, Herbert J. Meiselman, Özlem Doğan, Michael J. Simmonds, Alphan Sennaroğlu, Havva Yağcı Acar, Abdullah Muti and Işınsu Baylam. Their work appears in journals such as Chemical Engineering Journal, Nanoscale and Journal of Antimicrobial Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026